Received Jun 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | Unknown | — |
The patient received RabAvert dose on day 0 but did not receive second dose on day 7; Case reference number US-BN-2025-001895 is a spontaneous case initially received from a pharmacist via Bavarian Nordic (reference number: CASE-000976) on 01-Dec-2025 and concerns a female patient of an unknown age. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient received a dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown), at an unknown dose, site or route of administration for unknown indication. As reported, the patient did not receive the vaccine on day 7 (explicitly coded as 'incomplete vaccine administration'). At the time of the initial report, it was unknown if the patients experienced any adverse events due to RabAvert. No further information was provided.; Reporter's Comments: A female patient of an unknown age received a dose of RabAvert for unknown indication. As reported, the patient did not receive the vaccine on day 7, which is considered as incomplete vaccine administration. It was unknown if the patient experienced any adverse events due to RabAvert. Incomplete course of vaccination is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of an unknown age received a dose of RabAvert for unknown indication. As reported, the patient did not receive the vaccine on day 7, which is considered as incomplete vaccine administration. It was unknown if the patient experienced any adverse events due to RabAvert. Incomplete course of vaccination is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.